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1980 Beaumont Lecture
Restriction enzymes as tools for genetic research
Hamilton O. Smith, MD*

I am especially pleased to be here again at Henry Ford
Hospital to give the 1980 Beaumont Lecture because it was
here, during my medical residency from 1959 to 1962, that
my interest in molecular biology developed. This interest
eventually turned me toward a research career and led me
into work on the restriction enzymes that I will speak about
tonight.
As many of you may know from news media accounts,
restriction enzymes are nucleases that can cleave chromosomes or molecules of DNA (deoxyribonucleic acid) at
very specific points to yield unique sets of fragments.
Fragments of DNA from different sources can be rejoined to
give what is usually referred to as recombinant DNA. If
recombinant DNA is constructed so that a fragment of
DNA containing a gene is joined into a plasmid or viral
DNA molecule, the hybrid plasmid or virus can be propagated in bacteria to produce an unlimited supply of the
inserted gene or its products. This process is called gene
cloning. To understand the enormous impact of these new
techniques on biological research, one must know something about the state of biology just before their introduction. Very briefly, I will try to give you some perspective
before I describe the properties of restriction enzymes and
their applications. I shall also comment on the future of
recombinant DNA and express my views of the biohazard
controversy.

A Perspective
I am an M D , but I like to think of myself as a molecular
biologist. Like a lot of others in the 50s and 60s, I was
attracted to research by several important biological questions. What determines heredity at the molecular level?
How is genetic information stored and transmitted so ac-
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curately from generation to generation? How is the intricate
genetic program played out in individual cells as development occurs? How are genes arranged on chromosomes?
How are they expressed?
The molecular biologists who had entered the field a few
years before me had already begun to explore simple
organisms like bacteria and viruses and were finding some
of the answers for these simple procaryotes. It was determined that DNA was the genetic material which carried
hereditary information. Chemically, DNA is a polymer,
each strand of which consists of a repeating sugar-phosphate backbone to w h i c h four different purine and
p y r i m i d i n e bases are attached. Watson and Crick (1)
showed that DNA contains two strands, intertwined in a
helix, so that complementary bases are paired: adenine (A)
to thymine (T), and guanine (G) to cytosine (C). The complementary pairing provides the means for self-replication,
while the sequence of the four bases along each strand
serves as a code for storing genetic information, not unlike
the storage of information on a computer tape in binary
code. They found that, by mapping of mutations (changes
in the base sequence), genes were simply contiguous sequences of a few hundred bases and specified individual
proteins. To be expressed, a gene is first transcribed into an
RNA copy. The RNA is then translated into protein via a
complex cytoplasmic mechanism employing ribosomes.
Three bases are needed to specify each amino acid in the
protein according to a universal triplet code. DNA simply
stores the genetic information, while the synthesis of proteins converts the linear sequence information of each gene
into a three dimensional form, creating the structure which
carries out gene function.
In 1962 when 1 entered the field, biologists were just
beginning to get a glimmering of how genes were arranged
in bacteria and how their orderly expression was achieved.
In fact, my first exposure to these exciting new concepts
came when I read early copies of the journal of Molecular
Biology while sitting after lunch in the Henry Ford Hospital
Library. Jacob and Monod (2) had shown that related genes
were clustered into functional groups which they called

Smith

operons. The expression of the genes in an operon was
coordinately controlled through regulatory proteins called
repressors or activators. The mapping of genes on the
bacterial chromosome came along rapidly with the use of
the conventional genetic methods of mutational analysis,
complementation grouping, and genetic mapping by recombination. These methods were sufficient to provide, by
the mid-60s, a fairly satisfactory picture of how the genes of
bacteria and bacterial viruses worked.
Around this time, molecular biologists became bored with
the simpler organisms and many of them turned to higher
organisms. The goal was to understand the genetics and
developmental biology of man himself. But when mammalian cells (or, for that matter, the cells of most eucaryotes) were e x a m i n e d , they were found to be too
complex for the conventional kinds of genetic analysis
used so successfully with bacteria and their viruses. The
chromosomes were very much larger and contained tens of
thousands of genes. A new approach was needed: somehow the chromosomes had to be taken apart so that smaller
sections could be analyzed. It was at this point that restriction enzymes entered the picture as the key to the new
approach.

Restriction Enzymes
Restriction enzymes are sequence-specific endonucleases
which can be found in bacteria. Since different strains of
bacteria carry restriction enzymes of different specificities.

there are actually a large number of different restriction
enzymes. Figure 1 shows an example of E. coli, strain K.
This cell has a double-stranded, circular chromosome carrying a gene which codes for a restriction endonuclease.
The enzyme is shown here symbolically as a pair of scissors
because it cuts DNA at particular base sequences; for
example, 5'-GAATTC would be a typical sequence. Now,
of course, that would cause suicide of the cell if the
enzyme were unopposed, so, at the same time, the bacterial cell contains the gene for another enzyme, called a
modification enzyme or modification methylase. This enzyme puts a methyl group on one of the bases on each
strand within the recognition site, thus protecting the chromosome against cleavage by the restriction enzyme. The
two genes together form a restriction-modification system,
which appears to be a type of protective mechanism forthe
bacterial cell. If a virus that has been grown on another
strain (e.g., E. coli B) should infect that cell, that virus will
contain DNA which is modified for the B-type restriction
system but not for the K-type. So when the DNA is injected
into the cell, it will be rapidly cleaved by the restriction
endonuclease at the unprotected sites. Exonucleases present in the cell then chew the fragments into nucleotides,
so that the virus is inactivated. Biologically, we can think of
restriction and modification enzymes as providing a DNA
immunity system for the bacterial cell.
This picture, as 1 have described it, was largely worked out
by Werner Arber and his colleagues in the early and
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Fig. 1
Diagram representing the mechanism of restriction and modification in bacteria.

Restriction Enzymes

mid-60s (3). As it turns out, things are actually a bit more
complicated. There are really two types of restriction enzymes. Type I enzymes are proteins of high molecular
weight which recognize particular sequences in DNA but
cleave the DNA at random positions some distance from
the original recognition site. Furthermore, because these
enzymes require co-factors such at ATP and S-adenosyl
methionine, they are mechanistically very complicated.
They were first isolated and studied by Linn and Arber (4)
and by Meselson and Yuan at Harvard in 1967 and 1968
(5). They have not been useful in recombinant DNA work
because they do not cleave specifically. However, their
description was important in the development of the sitespecific restriction enzymes.
I read the Meselson and Yuan paper in the spring of 1968,
and it alerted me to the nature of these enzymes and to the
properties they possessed. At the time, my laboratory at
Johns Hopkins was studying genetic transformation of
Haemophilus influenzae Rd. By chance, we observed that
DNA from foreign sources was degraded, and we immediately drew the correct conclusion that a restriction enzyme was involved. Our enzyme not only recognized
specific sites but also cleaved within them (6). Our most
important work was to determine the cleavage site sequence: (5')GTPy| PuAC on each strand o f t h e DNA with
cleavage between the pyrimidine (Py) and purine (Pu), as
indicated by the vertical line (7). An important property of
the sequence was its symmetry; if read in the 5 ' to 3'
direction on one strand, the sequence is identical to that
read in the 5 ' to 3 ' direction on the complementary strand.
The enzyme thus recognizes both strands as being the same
and can make a symmetric cleavage on each strand.
Our enzyme, as distinguished from Type I, was the first o f a
large class of Type 11 enzymes with specific cleavage
properties. It was simpler than that of Meselson and Yuan,
because it required only magnesium ion as a co-factor and
cleaved within the recognition site. By current terminology,
the enzyme is called H/ndll, a shorthand notation indicating that it comes from H. influenzae, serotype d, cells. The
Hindm

Roman numeral indicates that this is the second such
restriction-modification system in this bacterial strain (8).
As of 1980, some 200 different restriction enzymes have
been found in various bacterial strains, and more than 50
different cleavage site sequences have been determined
(9). Enzymes have been found for 23 different sequences of
length 6 and for 9 sequences of length 4. Some, like hi ind W,
cleave degenerate sequences, i.e., those in which not all
the bases are exactly specified. Some enzymes recognize 5
base-pair sequences, and a few recognize asymmetric sequences and cleave specifically a few bases away from the
site.
Figure 2 illustrates the nature and frequency of the cleavage. As examples, sites for the restriction endonucleases
H/ndlll and Alu \ are shown on a section of hypothetical
DNA sequence. H/ndlll makes a staggered cleavage in a
symmetrical 6 base-pair sequence, while A l u \ makes an
even cut in a 4 base-pair sequence. The H/ndlll ends are
self-complementary, a property called "sticky" because
they tend to reassociate and are readily rejoined by an
enzyme called DNA ligase. H/ndIll-generated fragments
from any DNA source can be rejoined at random to
produce recombinant DNA. Alu \ fragments, on the other
hand, are blunt ended and can be joined to any other
blunt-ended DNA fragments, no matter how produced. The
reaction is less efficient, however.
Another point is that the frequency of occurrence of a
sequence depends on its length. The 6 base-pair H/ndlll
sequence occurs about once every 4,000 base pairs along
the DNA, thus giving fairly large pieces of the chromosome
containing several genes; whereas A/ul recognizes only 4
base pairs, occurring in DNA on the average about every
250 base pairs and giving small fragments that are often
below the size of the gene. That's actually all one needs to
know about restriction enzymes. They are site-specific
endonucleases capable of cutting at any of a variety of
preselected DNA sequences and allow us great flexibility
in how we carve up a chromosome.
Alul

Alul

• AGCATGGTCGAAGCTTGCCACCCTTAGCTATTATCGATTGATCCGGGCAGCTTTATATTGCAT •
• TCGTACCAG(nTCGAACGGTGGGAATC6ATAATAGCTAACTAGGCCCGTCGAAATATAACGTA •

Hindlll
AGCATGGTCGA
TCGTACCAGCTTCGA

Alul

Alul

AGCTTGCCACCCTTAG ^ CTATTATCGATTGATCCGGGCAG
AGGGTGGGAATC
GATAATAGCTTTCTAGGCCCGTC

CTTTATATTGCAT
GAAATATAACGTA

Fig. 2
A sample DNA sequence illustrating blunt and staggered types of restriction enzyme cleavage and the greater relative frequency of 4 base-pair
sequences.
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There are three major applications of restriction enzymes:
1) restriction mapping of chromosomes, 2) DNA sequencing, and 3) recombinant DNA and gene cloning. Together,
they constitute a whole new approach to genetic analysis
that can be applied not only to bacteria but also to the cells
of higher organisms.

Restriction Mapping
Credit for the development of restriction mapping goes to
Daniel Nathans and his co-workers at Johns Hopkins (10).
He began work on the SV40 tumor virus chromosome
about 1969 but found it difficult to use conventional genetic analysis. When I told him about my new restriction
enzyme, he realized that he could use it to cleave the SV40
chromosome into a number of discrete fragments as a basis
for analysis. Let me give you a kind of word picture — I
don't have his illustrations — of how he proceeded to
analyze this small viral chromosome.
He cleaved the DNA into 13 pieces with a mixture of the
H/ndII and H/ndlll restriction enzymes. He then determined the order of those fragments so as to construct a
physical map of the chromosome. Next, he determined
which fragments contained the origin of replication simply
by introducing a radioactive label at the time replication in
the chromosome began and looking to see which fragment
became radioactive. By the same procedure, he was able to
work out where repl ication ended and to show that repl ication proceeded bi-directionally from the origin and ended
ata point almost 180° away. This is something that he could
not easily have found out by the usual genetic or molecular
biological procedures.
Nathans then went on to ask which genes are contained in
each fragment. One of the important questions at the time
was which part of the chromosome contained the genes
that transformed tissue culture cells into tumor cells. To
determine this, he simply cut the DNA into fragments and
added individual purified fragments to tissue culture cells.
In this way, he was able to determine that a certain fragment, or set of fragments, carried the oncogenic genes.
Furthermore, he could map genetic mutants by localizing
the mutations in individual fragments. All the genetic properties could thus be ordered relative to his physical fragment map. This same sort of restriction analysis has now
been applied to several other animal viruses and to isolated
fragments of chromosomes, including our own.

DNA Sequencing
In 1975, Fred Sanger (11), working at Cambridge, and
Maxam and Gilbert (12), working at Harvard, developed
two revolutionary rapid-sequencing methods, both based

T

C
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A

Fig. 3
A first attempt by the author at D N A sequencing w i t h the Maxam-Gilbert
procedure. The sequence is that of a spacer D N A segment in cloned sea
urchin histone D N A .

on the use of restriction fragments. To sequence a particular
fragment by the Maxam-Gilbert procedure, we label it at
one end with radioactive phosphorus and then subject it to
a series of four different chemical cleavage reactions, each
of which is specific, or nearly specific, for one of the bases
G, A, T, or C. Take the case of the G reaction, for example.
It is designed so that each individual DNA molecule is
cleaved about once at a position where G occurs on the
strand. Thus, one obtains molecules of various lengths,
each with a labeled terminus and ending at one of the
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Fig. 4
Basic steps in gene cloning. Adapted from Newsweek magazine.

different G positions. These can be separated according to
size by gel electrophoresis. The size then indicates the
position of each G in the sequence with respect to the
labeled end. The gel lane for each reaction thus gives an
irregular ladder, the rungs of which indicate the positions
of that base. A complete sequence can easily be read from
the four parallel gel tracts (Fig. 3). It is possible to read
some 200 to 300 bases from any labeled terminus. The
Sanger procedure is similar except that chain-terminating
nucleoside triphosphates are used in a DNA synthesis
reaction to obtain labeled fragments terminating with specific bases. The techniques are truly revolutionary and
allow one to look at genes at the atomic level.

Recombinant DNA and Gene Cloning
Finally, we come to the construction of recombinant DNA
and the cloning of recombinant molecules. Figure 4,*
adapted from an article in Newsweek (March 17, 1980),
illustrates what one does in cloning. The bacterial cell is
usually E. coli. It contains small, circular extrachromosomal DNA elements called plasm ids which are isolated and
cleaved into linear molecules with a restriction enzyme.
The figure shows cleavage of the cohesive or sticky-ended
type because this is most readily rejoined. The DNA to be
cloned (for example, human DNA) is cleaved with the
restriction enzyme to produce fragments with the same
type of sticky ends. By incubating the two together and
joining with DNA ligase, we can form recombinant DNA
molecules consisting of plasmid and inserted human DNA.
The hybrid molecules are then put back into the E. coli
cells. The bacteria are made permeable to DNA by soaking

'Reprinted with permission of the artist Bob Conrad.

them in a calcium chloride solution. Finally, the cells
carrying hybrid plasmids are plated on an agar dish and
produce pure bacterial clones c a r r y i n g recombinant
plasmids.
A problem with this approach is that one is rarely able to
isolate a desired gene directly from the chromosome. For
example, i f w e want the insulin gene from human DNA, it
is not yet possible to isolate just that gene and insert it in
pure form into plasmid molecules. Instead, we clone a socalled "shotgun mixture" of fragments from the whole
genome and obtain what is, in effect, a whole library of
hybrid plasmids. But when these are introduced back into
individual bacterial cells, we have the problem of selecting
the particular one of interest from among the thousands of
clones on the plates. This calls for a great deal of cleverness
on the part of the scientist, but it can be done; the techniques for doing it are improving steadily. It is now possible
to screen 10 to 100,000 clones on a number of pie-sized
agar dishes.
Gene cloning has provided a new dimension of genetic
analysis. It makes available essentially unlimited supplies
of pure genes and gene products. Scientists around the
world are selecting genes from many sources for detailed
study at the sequence level. Examples are histone genes,
ribosomal RNA genes, and immunoglobulin genes. Studies
o f t h e last are revealing the genetic basis for i m m u noglobulin structure and diversity. Using bacteria as factories to produce protein products from c l o n e d genes
promises to have important industrial, medical, and research applications.
As an example of how gene cloning can work in basic
research, in my laboratory we have inserted the restriction
and modification genes from Haemophilus haemolyticus
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into a small bacterial plasmid called pBR322 and cloned
the hybrid plasmid in E. coli (13). Each bacterial cell carries
20 to 30 copies of the recombinant plasmid and therefore
of the restriction and modification genes as well. The
overproduction of restriction enzyme and modification
enzyme is proportional to the gene copy number, so we
now have a high yield source of our enzymes.

ate restriction enzyme and polydG extensions are added.
Now, the homopolymer extensions are complementary
and readily stick together to form recombinant DNA. These
recombinants are introduced into individual bacterial cells,
which are plated onto nutrient agar dishes. Tens of thousands of clones may grow up, but with current techniques,
these can be picked up on nitrocellulose membrane filters
and the DNA within each colony released in situ on the
membrane. O n e then identifies the insulin clones by
hybridizing radioactive insulin cDNA, or messenger, to
DNA from the clones that have become fixed to the filter.
The radioactive probe hybridizes only to DNA from the
clones containing the insulin gene.

To study these genes, we sequenced the DNA insert and
then fed the sequence into a computer. We asked it to find
the genes by surveying triplets of bases for an uninterrupted
frame using the genetic code table. Each gene begins with
an ATG initiation triplet and ends with a UAA or UGA
termination triplet. The computer then translated each gene
sequence into the amino acid sequence for the enzymes,
which saved us the laborious work of sequencing the
proteins directly. It should be emphasized that the cloning
approach allows us to take the genes out of their natural
habitat in the largely unexplored Haemophilus genome
and put them into a small plasmid molecule where they are
easily accessible to study. This allows us to perform an
analysis against the background of the genetically welldefined E. coli cell.

But possessing the clone is not enough. The human gene
does not function properly in a bacterial cell because the
genetic signals governing transcription and translation are
not compatible. To engineer a high efficiency, insulin overproducer clone, eukaryotic regulatory signals in front ofthe
gene must be replaced with analogous bacterial signals
(Fig. 6). To improve on the insulin gene, a leader sequence
is attached to it that specifies secretion of the insulin
molecule through the membrane and into the medium (Fig.
6).

Medical and Industrial Applications
of Recombinant DNA

The clone is now fully engineered to be a bacterial factory
(Fig. 7). Cells are grown in a large vat of culture medium.
The bacterial chromosome is shown as a wadded-up,
thread-like structure. The circular plasmid DNA molecules
carrying the insulin gene are present in many copies,
usually 20 to 30 per cell. Each gene is being translated into
insulin molecules. Because ofthe leader sequence (Fig. 6),
each insulin molecule is secreted.

We can expect some very exciting commercial applications of gene cloning in the future. The cloning of human
insulin and interferon genes has received a great deal of
press coverage, and with good reason. What are the steps
involved in such cloning? How is large scale production of
a gene product obtained? Let's take human insulin as the
example. In Figures 5-7 I have pictured my conception o f a
feasible process.

Afinal problem is thatthe gene, as pictured in Figure 6, has
been cloned as proinsulin, i.e., it contains the C segment of
proinsulin in addition to the A and B segments of the
mature insulin molecule. The bacteria do not contain an
enzyme to convert proinsulin into active insulin. However,
the large quantities of proinsulin being produced by the
factory are extracted from the suspension and treated with
a proteolytic enzyme like trypsin to break off the C fragment, leaving the active A and B fragments of insulin. With
a scheme similar to the one I have outlined, insulin could
be produced in good quantity within the next two to three
years.

In Figure 5, the messenger for the insulin gene is being
translated into insulin molecules in human islet cells. These
cells are broken open to gently release the translation
system, which is called polysomal RNA and can be isolated by centrifugation methods. Of course, one is not
isolating just the insulin messenger, but also messengers for
many other genes as well. The various RNA species are
extracted from polysomal RNA and converted into DNARNA hybrid molecules using reverse transcriptase. The
RNA strands are removed by sodium hydroxide treatment
to leave single-stranded DNA copies of the RNA, which are
then converted to double-stranded copies, using
Kornberg's DNA polymerase. The overall effect of these
steps is to convert the messenger RNA molecules back to
the original double-stranded DNA coding regions from
which they were derived. Next, polydC extensions are
added using the enzyme terminal transferase. In a separate
test tube, the plasmid DNA is linearized with an appropri-

Interferon is another protein that has been played up
greatly in the press in the past few months. This is an
antiviral agent which we hope will act in much the same
way as an antibiotic does for bacterial infections. A group
in Zurich headed by Charles Weissmann reported in January that they have isolated an E. coli clone which is
producing active interferon. They released the news to the
press before their work was published in a scientific jour-

10

Restriction Enzymes

CLONING THE INSULIN GENE

PLASMID
pBR322

HUMAN ISLET CELL
* iVUU vuv* POLYSOMAL RNA

I

mRNA

DIGEST

lr REVERSE TRANSCRIPTASE

I

1 NaOH; POLYMERASE
DS

cDNA

GGGG—

GGGG

CCCC

C E L L DNA

RECOMBINANT

o o
^

PLATED

o

0

COLONIES
Fig. 5
steps used to obtain a human insulin gene clone.
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Fig. 6
Engineering the human insulin gene clone for high level expression in bacteria.

nal, and there has been some discussion in the scientific
community about this means of publication. However, the
actual paper recently appeared in Nature (14), and they
indeed have developed a strain of E. coli that produces
small amounts of active interferon.

The Biohazards Controversy
I can't end my lecture without a brief comment on the
biohazard controversy. The whole question of possible
hazards was actually brought up by scientists themselves in
1974-1975. 1 was on sabbatical in Switzerland during that
period and did not have any part in the considerations, but
my colleague Daniel Nathans played an important role in
initiating the NIH guidelines for recombinant DNA research. These said, in effect: "We are mixing genes from
different organisms, some of which carry possibly dangerous genes. Could more dangerous disease-producing
species be produced accidentally? Let's carryout recombinant DNA work carefully, under conditions of both biological and physical containment, until we have learned more
about its safety." Biological containment means using bacteria that are weak and will not grow outside the laboratory.

What are some of the other products one can make with
recombinant DNA techniques? One that comes to mind
immediately is growth hormone. There is not a large market for this, so it is probably low on the pharmaceutical list.
In the same category are blood clotting factors. On the
other hand, there are several obvious, and possibly lucrative, industrial applications: organisms to improve alcoholic fermentation, organisms to synthesize organic
compounds that are difficult to make by chemical synthesis, and organisms to eat oil or other environmentally
hazardous wastes. The possibilities seem almost limitless.
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Fig. 7
A simplified factory for production of human insulin from a bacterial clone.

bacteria, which have the ability to carry out what is called
"illegitimate recombination," i.e., shuffling of segments of
DNA more or less at random. We've learned that these
elements are actually producing recombinant DNA in nature all the time. Although widespread crossing of species
barriers probably does not happen, it is almost certainly
occurring at a low level. Because of this new information, a
number of scientists have become bolder in their statements about the safety of recombinant DNA procedures.
Furthermore, no dangerous strain has surfaced during the
eight years that this kind of work has been going on, while
the benefits have become more prominent. The result is
that in January the recombinant DNA committee at the NIH
relaxed the guidelines by essentially two orders of magnitude, making most of the P3 experiments now legitimate at
the PI level. This has been a tremendous advance. Now
we'll see a much greater acceleration of this kind o f w o r k ,
and I think we'll see many benefits from it. I believe
recombinant DNA work is safe.

Physical containment now exists at four levels. PI work is
done in a regular laboratory using standard microbiological
techniques. P2 work is essentially the same except that the
laboratory is closed with only limited access permitted. P3
containment requires special rooms, special cabinets for
doing the bacterial transfers, negative air pressure, etc, and
gowns and gloves are worn. P4 is the ultimate containment: experiments are done, essentially, in a glove box
with nothing exposed to the environment.
Much of the work that I described from our laboratory was
done in P3 containment, and it was a considerable hindrance. We had to construct a special laboratory, and our
work was delayed at least a year while the laboratory was
built. Since many universities could not afford to construct
these special facilities, work was restricted to a considerable degree.
During the years since 1975 we've continued to. learn a
great deal about what is occurring in nature. We've learned
about little DNA elements called transposons, and insertion sequences that are found in higher cells and also in

Thank you.
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